Search
Journey Medical Corp
DERMAdd to Watchlist
6.700USD
0.0000.00%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
183.14MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-23The current earnings forecast score of Journey Medical Corp is 8.00, ranking 56 out of 157 in the Pharmaceuticals industry. The average price target is 13.00, with a high of 16.00 and a low of 12.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
13.500
Target Price
+109.95%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
177
Total
6
Median
8
Average
Company name
Ratings
Analysts
Journey Medical Corp
DERM
4
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
36
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Journey Medical Corp's expected revenue for the next quarter?
Journey Medical Corp's expected revenue is 18.37M.
What is Journey Medical Corp's price target?
Analysts forecast that Journey Medical Corp's price target is USD 13.00, with the highest forecast at USD 16.00 and the lowest forecast at USD 12.00.
How have Journey Medical CorpDERM's recent earnings per share performed?
The market expectation was USD -0.08, while Journey Medical CorpDERM's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD -0.01.
What is the analyst rating for Journey Medical Corp?
Based on the ratings of Journey Medical Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
